BDBM231227 US9346782, 7a::US9346782, 7b::US9346782, 7c

SMILES COc1nc2ccc(cc2c(Cl)c1Cc1ccc(cc1)C(F)(F)F)C(O)(C#C)C1CN(C1)C(C)=O

InChI Key InChIKey=HWLRVNIRYWWAOZ-UHFFFAOYSA-N

Data  3 IC50  3 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 231227   

TargetNuclear receptor ROR-gamma [258-518](Artificial Sequence)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM231227(US9346782, 7b | US9346782, 7c | US9346782, 7a)
Affinity DataKd:  300nMpH: 7.0 T: 2°CAssay Description:ThermoFluor® experiments were carried out using instruments owned by Janssen Research and Discovery, L.L.C. through its acquisition of 3-Dimensio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor ROR-gamma [258-518](Artificial Sequence)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM231227(US9346782, 7b | US9346782, 7c | US9346782, 7a)
Affinity DataKd:  230nMpH: 7.0 T: 2°CAssay Description:ThermoFluor® experiments were carried out using instruments owned by Janssen Research and Discovery, L.L.C. through its acquisition of 3-Dimensio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor ROR-gamma [258-518](Artificial Sequence)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM231227(US9346782, 7b | US9346782, 7c | US9346782, 7a)
Affinity DataKd:  49nMpH: 7.0 T: 2°CAssay Description:ThermoFluor® experiments were carried out using instruments owned by Janssen Research and Discovery, L.L.C. through its acquisition of 3-Dimensio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor ROR-gamma [258-518,Y502F](Artificial Sequence)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM231227(US9346782, 7b | US9346782, 7c | US9346782, 7a)
Affinity DataIC50: 230nMAssay Description:The reporter assay was performed by transiently transfecting HEK293T cells with 5 μg of pBIND-RORγt LBD or pBIND-RORγt LBD-AF2 and 5 &...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor ROR-gamma [258-518,Y502F](Artificial Sequence)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM231227(US9346782, 7b | US9346782, 7c | US9346782, 7a)
Affinity DataIC50: 360nMAssay Description:The reporter assay was performed by transiently transfecting HEK293T cells with 5 μg of pBIND-RORγt LBD or pBIND-RORγt LBD-AF2 and 5 &...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor ROR-gamma [258-518,Y502F](Artificial Sequence)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM231227(US9346782, 7b | US9346782, 7c | US9346782, 7a)
Affinity DataIC50: 98nMAssay Description:The reporter assay was performed by transiently transfecting HEK293T cells with 5 μg of pBIND-RORγt LBD or pBIND-RORγt LBD-AF2 and 5 &...More data for this Ligand-Target Pair
In DepthDetails
US Patent